CSO Andreas Busch resigns effective Sept 30, 2022

Cyclerion Therapeutics, Inc.

Andreas Busch, Ph.D. resigned as Chief Scientific Officer, effective Sept 30, 2022.
Dr. Busch left to pursue another opportunity; no disagreement with Company's operations, policies or practices.
No successor has been named; search process not disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andreas Busch, Ph.D.

Chief Scientific Officer

CYCN · Cyclerion Therapeutics, Inc.

Effective: 2022-09-30
Filed: September 30, 2022, 7:59 PM ET

On and effective September 30, 2022, Andreas Busch, Ph.D. resigned from his position as Chief Scientific Officer of Cyclerion Therapeutics, Inc. (the “Company”) to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andreas Busch, Ph.D. resigned as Chief Scientific Officer at Cyclerion Therapeutics, Inc..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

On and effective September 30, 2022, Andreas Busch, Ph.D. resigned from his position as Chief Scientific Officer of Cyclerion Therapeutics, Inc. (the “Company”) to pursue another opportunity.

View on SEC.gov

Cyclerion Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-019124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.